Shimon Izhakian
Overview
Explore the profile of Shimon Izhakian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naamany E, Azem K, Amor S, Awad S, Freidkin L, Rosengarten D, et al.
BMC Pulm Med
. 2025 Feb;
25(1):87.
PMID: 39984868
Background: Pulmonary alveolar proteinosis (PAP) presents a significant challenge due to its progressive and potentially fatal nature. Whole lung lavage (WLL) is a key treatment for primary PAP with respiratory...
2.
Izhakian S, Yehezkely R, Frajman A, Mekiten O, Hadar O, Rockland A, et al.
Chron Respir Dis
. 2025 Jan;
22:14799731241296847.
PMID: 39749821
Background: The paradigm of bronchiectasis is shifting away from its exclusive characterization as a neutrophilic condition. Patients with bronchiectasis and high eosinophil levels have been found to have a specific...
3.
Izhakian S, Gorenshtein A, Engelstein H, Freidkin L, Rosengarten D, Eldar O, et al.
Clin Exp Med
. 2024 Sep;
24(1):220.
PMID: 39271531
Hyperuricemia is a known predictor of World Health Organization (WHO) Group 1 pulmonary hypertension (PH) (pulmonary arterial hypertension), but its role in excluding PH secondary to chronic lung diseases (WHO...
4.
Izhakian S, Frajman A, Hayat A, Gorenshtein A, Shtraichman O, Freidkin L, et al.
Pulm Circ
. 2024 Aug;
14(3):e12427.
PMID: 39157053
The prognostic significance of pretransplant N-terminal pro-brain (B)-type natriuretic peptide (NT-proBNP) level has not been investigated in lung transplant recipients. The electronic files of 173 patients with chronic lung disease...
5.
Izhakian S, Igawa M, Chen Zion L, Mekiten O, Freidkin L, Rosengarten D, et al.
Clin Exp Med
. 2024 Jul;
24(1):172.
PMID: 39068615
Idiopathic pulmonary fibrosis (IPF) is a diagnosis of exclusion, requiring that potential etiologies of interstitial lung disease be ruled out. Antinuclear antibody (ANA) testing is commonly performed in individuals with...
6.
Frajman A, Izhakian S, Mekiten O, Hadar O, Lichtenstadt A, Hajaj C, et al.
Respir Res
. 2024 Jul;
25(1):278.
PMID: 39010067
Background: The global mortality and morbidity rates of bronchiectasis patients due to nontuberculous mycobacteria (NTM) pulmonary infection are on a concerning upward trend. The aims of this study to identify...
7.
Freidkin L, Kramer M, Rosengarten D, Izhakian S, Taieb S, Pertzov B
BMC Pulm Med
. 2024 May;
24(1):226.
PMID: 38724947
Background: Inhaled nitric oxide (iNO) selectively acts on the pulmonary vasculature of ventilated lung tissue by reducing pulmonary vascular resistance and intrapulmonary shunt. This effect may reduce ventilation/perfusion mismatch and...
8.
Freidkin L, Azem K, Pertzov B, Izhakian S, Rosengarten D, Kramer M
Respir Med Case Rep
. 2023 Nov;
46:101943.
PMID: 38025252
Broncho-biliary fistula (BBF) is an extremely rare but serious medical condition resulting from pathological communication between the biliary system and the bronchial tree. Treatment options include both surgical and non-surgical...
9.
Freidkin L, Heching M, Rosengarten D, Pertzov B, Gershman E, Izhakian S, et al.
Thorac Cancer
. 2023 Sep;
14(32):3226-3231.
PMID: 37704575
Background: Right middle lobe (RML) syndrome is a recurrent or chronic obstruction of the RML causing atelectasis of the right middle lobe due to mechanical and nonmechanical etiologies. The consequences...
10.
Izhakian S, Kramer M
Indian J Pathol Microbiol
. 2022 Oct;
65(4):944-945.
PMID: 36308215
No abstract available.